Form 4: Cardlytics Director Andre J. Fernandez Acquires 11,000 Restricted Stock Units

Director Andre J. Fernandez acquired 11,000 restricted stock units in Cardlytics, Inc. on May 20, 2025, which will vest in full on the one-year anniversary of the grant date.

Summary

• On May 20, 2025, Andre J. Fernandez, a director of Cardlytics, Inc., acquired 11,000 restricted stock units (RSUs).
• Each RSU represents a contingent right to receive one share of Cardlytics common stock or its cash equivalent, at the Issuer's election.
• The RSUs will vest in full on May 20, 2026, provided Fernandez remains a director of Cardlytics on that date.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The acquisition of RSUs by a director is generally a positive sign, indicating confidence in the company's future. However, it's a routine transaction and doesn't necessarily indicate a major shift in the company's prospects.

Positives

• The acquisition of RSUs by a director signals confidence in the company's future performance.

Future Outlook

The vesting of the RSUs is contingent on the director's continued service, aligning his interests with the company's long-term success.

Industry Context

Form 4 filings are routine disclosures that provide transparency into the transactions of company insiders, offering insights into their perspectives on the company's valuation and prospects.

Stakeholder Impact

• Shareholders may view the director's RSU acquisition as a positive signal, aligning management's interests with theirs.
• Employees may see this as a sign of stability and confidence in the company's leadership.

Key Dates

Keywords

Cardlytics, Director, RSU, Restricted Stock Units, Beneficial Ownership, Form 4, Fernandez, CDLX